Oral 28: Association Between Aspirin Use and Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study From the Third National Health and Nutrition Examination Survey

Paul Mustacchia, MD
Paul Mustacchia, MD

Author Insight from Paul Mustacchia, MD, Nassau University Medical Center, East Meadow, NY

What’s new here and important for clinicians?
This cross-sectional study was the first human study to investigate the association of aspirin and NAFLD based on the US population from NHANES III

What do patients need to know?
Aspirin may be associated with low prevalence of NAFLD in certain population group.

Read Abstract  Listen to the virtual press briefing

540_A oral 28

Author Contact
Paul Mustacchia, MD, Nassau University Medical Center, East Meadow, NY
pmustacc@numc.edu

 

Related Abstracts

P1441 Association between Caffeine Consumption and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis


Media Interview Requests:

To arrange an interview with any ACG experts or abstract authors please contact Jacqueline Gaulin of ACG via email jgaulin@gi.org or by phone at 301-263-9000.